I wouldn't rule out Fresenius by a longshot. Spoke with a nephroligiste who attend to mostly Fresenius clinics. He is WELL AWARE of Triferic and better patient outcomes will 'require' him to use Triferic.
RMTI closed down 7.5 percent on Tuesday, November 10, 2015, on 2.58 times normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.